Search
Anixa Biosciences Inc
ANIXAdd to Watchlist
2.790USD
+0.090+3.33%
Close 09-22 16:00（ET）
95.80MMarket Cap
LossP/E TTM
Anixa Biosciences Inc (ANIX) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Anixa Biosciences Inc in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
10.000USD+261.01%
ANIX Analyst Recommendation Trends
In the current month, ANIX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ANIX average Analyst price target in the last month is 10.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
4
4
4
3
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
3
4
4
4
4
ANIX Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
11
14
3
0
0
28
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
7
7
1
1
21
Financial Forecasting
Based on analysts' estimates, ANIX EPS is projected to reach -0.088 in FY2026Q4, following reported EPS of -0.076 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.10
-0.09
-0.09
-0.09
-0.08
Actual
-0.08
-0.07
-0.08
--
--
Surprise
+18.77%
+14.40%
+11.35%
--
--
FAQs
What is Anixa Biosciences Inc's price target?
Analysts forecast that Anixa Biosciences Inc's price target is USD 10.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 7.00.
How have Anixa Biosciences IncANIX's recent earnings per share performed?
The market expectation was USD -0.08, while Anixa Biosciences IncANIX's earnings per share (EPS) for the previous quarter was USD -0.07. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Anixa Biosciences Inc?
Based on the ratings of Anixa Biosciences Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.